Literature DB >> 24668648

Alcohol dehydrogenase III exacerbates liver fibrosis by enhancing stellate cell activation and suppressing natural killer cells in mice.

Hyon-Seung Yi1, Young-Sun Lee, Jin-Seok Byun, Wonhyo Seo, Jong-Min Jeong, Ogyi Park, Gregg Duester, Takeshi Haseba, Sun Chang Kim, Keun-Gyu Park, Bin Gao, Won-Il Jeong.   

Abstract

UNLABELLED: The important roles of retinols and their metabolites have recently been emphasized in the interactions between hepatic stellate cells (HSCs) and natural killer (NK) cells. Nevertheless, the expression and role of retinol metabolizing enzyme in both cell types have yet to be clarified. Thus, we investigated the expression of retinol metabolizing enzyme and its role in liver fibrosis. Among several retinol metabolizing enzymes, only alcohol dehydrogenase (ADH) 3 expression was detected in isolated HSCs and NK cells, whereas hepatocytes express all of them. In vitro treatment with 4-methylpyrazole (4-MP), a broad ADH inhibitor, or depletion of the ADH3 gene down-regulated collagen and transforming growth factor-β1 (TGF-β1) gene expression, but did not affect α-smooth muscle actin gene expression in cultured HSCs. Additionally, in vitro, treatments with retinol suppressed NK cell activities, whereas inhibition of ADH3 enhanced interferon-γ (IFN-γ) production and cytotoxicity of NK cells against HSCs. In vivo, genetic depletion of the ADH3 gene ameliorated bile duct ligation- and carbon tetrachloride-induced liver fibrosis, in which a higher number of apoptotic HSCs and an enhanced activation of NK cells were detected. Freshly isolated HSCs from ADH3-deficient mice showed reduced expression of collagen and TGF-β1, but enhanced expression of IFN-γ was detected in NK cells from these mice compared with those of control mice. Using reciprocal bone marrow transplantation of wild-type and ADH3-deficient mice, we demonstrated that ADH3 deficiency in both HSCs and NK cells contributed to the suppressed liver fibrosis.
CONCLUSION: ADH3 plays important roles in promoting liver fibrosis by enhancing HSC activation and inhibiting NK cell activity, and could be used as a potential therapeutic target for the treatment of liver fibrosis.
© 2014 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24668648      PMCID: PMC4867000          DOI: 10.1002/hep.27137

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  39 in total

1.  Absence of hepatic stellate cell retinoid lipid droplets does not enhance hepatic fibrosis but decreases hepatic carcinogenesis.

Authors:  Johannes Kluwe; Nuttaporn Wongsiriroj; Juliane S Troeger; Geum-Youn Gwak; Dianne H Dapito; Jean-Philippe Pradere; Hongfeng Jiang; Maham Siddiqi; Roseann Piantedosi; Sheila M O'Byrne; William S Blaner; Robert F Schwabe
Journal:  Gut       Date:  2011-01-27       Impact factor: 23.059

Review 2.  Liver: An organ with predominant innate immunity.

Authors:  Bin Gao; Won-Il Jeong; Zhigang Tian
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

3.  Suppression of experimental hepatic fibrosis by administration of vitamin A.

Authors:  H Senoo; K Wake
Journal:  Lab Invest       Date:  1985-02       Impact factor: 5.662

4.  Suppression of innate immunity (natural killer cell/interferon-γ) in the advanced stages of liver fibrosis in mice.

Authors:  Won-Il Jeong; Ogyi Park; Yang-Gun Suh; Jin-Seok Byun; So-Young Park; Earl Choi; Ja-Kyung Kim; Hyojin Ko; Hua Wang; Andrew M Miller; Bin Gao
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

Review 5.  Experimental models of hepatic fibrosis: a review.

Authors:  H Tsukamoto; M Matsuoka; S W French
Journal:  Semin Liver Dis       Date:  1990-02       Impact factor: 6.115

6.  Retinoic acid modulates rat Ito cell proliferation, collagen, and transforming growth factor beta production.

Authors:  B H Davis; R T Kramer; N O Davidson
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

7.  TLR4 enhances TGF-beta signaling and hepatic fibrosis.

Authors:  Ekihiro Seki; Samuele De Minicis; Christoph H Osterreicher; Johannes Kluwe; Yosuke Osawa; David A Brenner; Robert F Schwabe
Journal:  Nat Med       Date:  2007-10-21       Impact factor: 53.440

Review 8.  Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology.

Authors:  David W Crabb; Michinaga Matsumoto; David Chang; Min You
Journal:  Proc Nutr Soc       Date:  2004-02       Impact factor: 6.297

9.  Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid.

Authors:  Daniel Mucida; Yunji Park; Gisen Kim; Olga Turovskaya; Iain Scott; Mitchell Kronenberg; Hilde Cheroutre
Journal:  Science       Date:  2007-06-14       Impact factor: 47.728

10.  Differential modulation of rat hepatic stellate phenotype by natural and synthetic retinoids.

Authors:  Karine Hellemans; Peggy Verbuyst; Erik Quartier; Frans Schuit; Krista Rombouts; Ross A S Chandraratna; Detlef Schuppan; Albert Geerts
Journal:  Hepatology       Date:  2004-01       Impact factor: 17.425

View more
  29 in total

Review 1.  Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease?

Authors:  Wonhyo Seo; Won-Il Jeong
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 2.  Ocular mucous membrane pemphigoid: a review.

Authors:  Samanta Taurone; Marialuisa Spoletini; Massimo Ralli; Pietro Gobbi; Marco Artico; Laszlò Imre; Cecília Czakò; Illés Kovàcs; Antonio Greco; Alessandra Micera
Journal:  Immunol Res       Date:  2019-06       Impact factor: 2.829

Review 3.  Natural killer cells in inflammatory heart disease.

Authors:  SuFey Ong; Noel R Rose; Daniela Čiháková
Journal:  Clin Immunol       Date:  2016-11-25       Impact factor: 3.969

Review 4.  Pathobiology of liver fibrosis: a translational success story.

Authors:  Youngmin A Lee; Michael C Wallace; Scott L Friedman
Journal:  Gut       Date:  2015-02-13       Impact factor: 23.059

Review 5.  Mechanisms of hepatic stellate cell activation.

Authors:  Takuma Tsuchida; Scott L Friedman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-10       Impact factor: 46.802

6.  Effects of Gene Polymorphisms, Metabolic Activity, and Content of Alcohol Dehydrogenase and Acetaldehyde Dehydrogenases on Prognosis of Hepatocellular Carcinoma Patients.

Authors:  Na Gao; Jingjing Chen; Bing Qi; Tianyuan Zhao; Yuanyuan Guo; Yan Fang; Zixinying Han; Hai-Ling Qiao
Journal:  Turk J Gastroenterol       Date:  2022-07       Impact factor: 1.555

Review 7.  The antifibrotic role of natural killer cells in liver fibrosis.

Authors:  Yuan Wei; Wang Bingyu; Yang Lei; Yuan Xingxing
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-27

8.  Aldehyde dehydrogenase inhibition blocks mucosal fibrosis in human and mouse ocular scarring.

Authors:  Sarah D Ahadome; David J Abraham; Suryanarayana Rayapureddi; Valerie P Saw; Daniel R Saban; Virginia L Calder; Jill T Norman; Markella Ponticos; Julie T Daniels; John K Dart
Journal:  JCI Insight       Date:  2016-08-04

Review 9.  Alcohol and multiple sclerosis: an immune system-based review.

Authors:  Maryam Fahim; Aryan Rafiee Zadeh; Pouria Shoureshi; Keyvan Ghadimi; Masoumeh Cheshmavar; Neda Sheikhinia; Mahdieh Afzali
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2020-04-15

Review 10.  Hepatic stellate cells as key target in liver fibrosis.

Authors:  Takaaki Higashi; Scott L Friedman; Yujin Hoshida
Journal:  Adv Drug Deliv Rev       Date:  2017-05-12       Impact factor: 17.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.